Leelyn Smith, LLC GlaxoSmithKline Cap, Inc. 2.80 03/18/23 Call Options Transaction History
Leelyn Smith, LLC
- $543 Million
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|